FR2311550B2 - - Google Patents

Info

Publication number
FR2311550B2
FR2311550B2 FR7615554A FR7615554A FR2311550B2 FR 2311550 B2 FR2311550 B2 FR 2311550B2 FR 7615554 A FR7615554 A FR 7615554A FR 7615554 A FR7615554 A FR 7615554A FR 2311550 B2 FR2311550 B2 FR 2311550B2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7615554A
Other languages
French (fr)
Other versions
FR2311550A2 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FR2311550A2 publication Critical patent/FR2311550A2/fr
Application granted granted Critical
Publication of FR2311550B2 publication Critical patent/FR2311550B2/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7615554A 1975-05-23 1976-05-21 Nouveaux derives 3-thioles d'acides 7-acylamidocephalosporaniques, leur procede de preparation et medicament les contenant Granted FR2311550A2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/580,268 US4001409A (en) 1975-05-23 1975-05-23 Injectable formulations of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid

Publications (2)

Publication Number Publication Date
FR2311550A2 FR2311550A2 (fr) 1976-12-17
FR2311550B2 true FR2311550B2 (US20030199744A1-20031023-C00003.png) 1978-11-17

Family

ID=24320409

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7615554A Granted FR2311550A2 (fr) 1975-05-23 1976-05-21 Nouveaux derives 3-thioles d'acides 7-acylamidocephalosporaniques, leur procede de preparation et medicament les contenant

Country Status (4)

Country Link
US (1) US4001409A (US20030199744A1-20031023-C00003.png)
JP (1) JPS51142545A (US20030199744A1-20031023-C00003.png)
DE (1) DE2622985C3 (US20030199744A1-20031023-C00003.png)
FR (1) FR2311550A2 (US20030199744A1-20031023-C00003.png)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100512098B1 (ko) * 2001-12-10 2005-09-05 (주)마이크로바이오텍 레불린산 및 그의 유도체를 함유한 항생제, 화장품 및 식품

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867380A (en) * 1971-02-18 1975-02-18 Smithkline Corp 3-Heterocyclic thiomethylcephalosporins
US3855213A (en) * 1971-02-18 1974-12-17 Smith Kline French Lab 3-heterocyclic thiomethyl-cephalosporins
US3940483A (en) * 1971-02-05 1976-02-24 E. R. Squibb & Sons, Inc. Antibiotic compositions and method

Also Published As

Publication number Publication date
JPS5410618B2 (US20030199744A1-20031023-C00003.png) 1979-05-08
FR2311550A2 (fr) 1976-12-17
US4001409A (en) 1977-01-04
DE2622985C3 (de) 1978-11-02
DE2622985A1 (de) 1976-11-25
JPS51142545A (en) 1976-12-08
DE2622985B2 (de) 1978-03-09

Similar Documents

Publication Publication Date Title
JPS5410618B2 (US20030199744A1-20031023-C00003.png)
CH598445A5 (US20030199744A1-20031023-C00003.png)
BG20954A1 (US20030199744A1-20031023-C00003.png)
BG22239A1 (US20030199744A1-20031023-C00003.png)
BG22358A1 (US20030199744A1-20031023-C00003.png)
BG22707A1 (US20030199744A1-20031023-C00003.png)
BG23128A1 (US20030199744A1-20031023-C00003.png)
CH1597875A4 (US20030199744A1-20031023-C00003.png)
CH4975A4 (US20030199744A1-20031023-C00003.png)
CH577919A5 (US20030199744A1-20031023-C00003.png)
CH581745B5 (US20030199744A1-20031023-C00003.png)
CH586576A5 (US20030199744A1-20031023-C00003.png)
CH587706A5 (US20030199744A1-20031023-C00003.png)
CH588830A5 (US20030199744A1-20031023-C00003.png)
CH589281A5 (US20030199744A1-20031023-C00003.png)
CH590623A5 (US20030199744A1-20031023-C00003.png)
CH590956A5 (US20030199744A1-20031023-C00003.png)
CH591072A5 (US20030199744A1-20031023-C00003.png)
CH591195A5 (US20030199744A1-20031023-C00003.png)
CH591963A5 (US20030199744A1-20031023-C00003.png)
CH592717A5 (US20030199744A1-20031023-C00003.png)
CH592982A5 (US20030199744A1-20031023-C00003.png)
CH593044A5 (US20030199744A1-20031023-C00003.png)
CH593673A5 (US20030199744A1-20031023-C00003.png)
CH594232A5 (US20030199744A1-20031023-C00003.png)